Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of inhaled peramivir for uncomplicated influenza in adults
CTR20263264Phase 3Suspended
- Sponsor
- Langtian Pharmaceutical
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of peramivir in influenza, Influenza A infection, influenza B, sponsored by Langtian Pharmaceutical. Started Aug 2026; status: suspended.
02
Drugs
peramivir
03
Conditions
influenzaInfluenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20263264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263264.